Skip to Content

← See all DUO Fusion brands

DUO Fusion by Boehringer Ingelheim Pharmaceuticals, Inc.

Medically reviewed on September 11, 2016

Dosage form: tablet, chewable
Ingredients: Famotidine 10mg, Calcium Carbonate 800mg, Magnesium Hydroxide 165mg
Labeler: Boehringer Ingelheim Pharmaceuticals, Inc.
NDC Code: 0597-0320

DUOFUSION™
Famotidine 10 mg/Calcium Carbonate 800 mg
Magnesium Hydroxide 165 mg Tablets
Cool Mint Flavor

Drug Facts

Active ingredients
(in each chewable tablet)
Purpose
Famotidine 10 mgAcid Reducer
Calcium carbonate 800 mgAntacid
Magnesium hydroxide 165 mgAntacid

Use relieves heartburn associated with acid indigestion and sour stomach

Warnings
Allergy alert: Do not use if you are allergic to famotidine or other acid reducers

Do not use

  • if you have trouble or pain swallowing food, vomiting with blood, or bloody or black stools. These may be signs of a serious condition. See your doctor.
  • with other acid reducers

Ask a doctor before use if you have

  • had heartburn over 3 months. This may be a sign of a more serious condition.
  • heartburn with lightheadedness, sweating, or dizziness
  • chest pain or shoulder pain with shortness of breath; sweating; pain spreading to arms, neck or shoulders; or lightheadedness
  • frequent chest pain
  • frequent wheezing, particularly with heartburn
  • unexplained weight loss
  • nausea or vomiting
  • stomach pain

Ask a doctor or pharmacist before use if you are presently taking a prescription drug. Antacids may interact with certain prescription drugs.

Stop use and ask a doctor if

  • your heartburn continues or worsens
  • you need to take this product for more than 14 days

If pregnant or breast-feeding, ask a health professional before use.
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away. (1-800-222-1222)

Directions

  • adults and children 12 years and over:
    • do not swallow tablet whole: chew completely
    • to relieve symptoms, chew 1 tablet before swallowing
    • do not use more than 2 chewable tablets in 24 hours
  • children under 12 years: ask a doctor

Other information

  • each tablet contains: calcium 330 mg; magnesium 70 mg
  • Phenylketonurics: Contains phenylalanine 2.2 mg per tablet
  • read the directions and warnings before use
  • read the bottle label. It contains important information.
  • store at 20-25°C (68-77°F)
  • protect from moisture

Inactive ingredients anhydrous lactose, aspartame, dextrates, ferric oxide, glyceryl monostearate, lactose monohydrate, magnesium stearate, microcrystalline cellulose, natural peppermint flavor, polyacrylate dispersion, polysorbate 80, povidone, pregelatinized starch, sodium starch glycolate, talc

Questions? Call 1-888-285-9159 (English/Spanish) M – F, 8:30 – 5 EST, or visit www.DuoFusion.com

Distributed by: Boehringer Ingelheim (BI) Consumer Health Care Products Division of BI Pharmaceuticals, Inc., Ridgefield, CT 06877. © 2016, BI Pharmaceuticals, Inc. All rights reserved.

DUO Fusion™ 20 ct Label
NDC: 0597-0320-35

DUO Fusion™ 34 ct Label
NDC: 0597-0320-70

DUO Fusion™ 55 ct Label
NDC: 0597-0320-69

DUO FUSION 
famotidine, calcium carbonate, magnesium hydroxide tablet, chewable
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:0597-0320
Route of AdministrationORALDEA Schedule    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
Famotidine (Famotidine) Famotidine10 mg
Calcium Carbonate (CARBONATE ION) Calcium Carbonate800 mg
Magnesium Hydroxide (HYDROXIDE ION) Magnesium Hydroxide165 mg
Inactive Ingredients
Ingredient NameStrength
ANHYDROUS LACTOSE 
ASPARTAME 
DEXTRATES 
FERRIC OXIDE RED 
GLYCERYL MONOSTEARATE 
LACTOSE MONOHYDRATE 
MAGNESIUM STEARATE 
CELLULOSE, MICROCRYSTALLINE 
METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER (1:1) TYPE A 
POLYSORBATE 80 
POVIDONES 
STARCH, CORN 
SODIUM STARCH GLYCOLATE TYPE A POTATO 
TALC 
Product Characteristics
ColorPINKScoreno score
ShapeROUNDSize17mm
FlavorMINTImprint Code
Contains    
Packaging
#Item CodePackage Description
1NDC:0597-0320-3520 TABLET, CHEWABLE in 1 BOTTLE
2NDC:0597-0320-7034 TABLET, CHEWABLE in 1 BOTTLE
3NDC:0597-0320-6955 TABLET, CHEWABLE in 1 BOTTLE
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
ANDAANDA07735503/01/2016
Labeler - Boehringer Ingelheim Pharmaceuticals, Inc. (603175944)
Registrant - Boehringer Ingelheim Pharmaceuticals, Inc. (603175944)
Establishment
NameAddressID/FEIOperations
Perrigo006013346MANUFACTURE(0597-0320)

 
Boehringer Ingelheim Pharmaceuticals, Inc.

← See all DUO Fusion brands

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide